Immunotherapy of Allergic Disease
- 1 January 2004
- book chapter
- Published by Elsevier
- Vol. 82, 105-153
- https://doi.org/10.1016/s0065-2776(04)82003-0
Abstract
No abstract availableThis publication has 291 references indexed in Scilit:
- Antibody Binding of Deletion Mutants of Asp f 2, the Major Aspergillus fumigatus AllergenBiochemical and Biophysical Research Communications, 2000
- Comparison of skin prick test with serially diluted wild-type and genetically engineered recombinant Der f2Annals of Allergy, Asthma & Immunology, 2000
- The expanding universe of T-cell subsets: Th1, Th2 and morePublished by Elsevier ,1999
- Decreased release of histamine and sulfidoleukotrienes by human peripheral blood leukocytes after wasp venom immunotherapy is partially due to induction of IL-10 and IFN-γ production of T cellsJournal of Allergy and Clinical Immunology, 1999
- Recombinant allergen fragments as candidate preparations for allergen immunotherapyJournal of Allergy and Clinical Immunology, 1997
- Oral immunotherapy with grass pollen in enterosoluble capsulesEuropean Journal of Pediatrics, 1990
- Human immune responsiveness to Lolium Perenne pollen allergen Lol p III (Rye III) is associated with HLA-DR3 and DR5Human Immunology, 1989
- Allergen-controlled study of intranasal immunotherapy for ragweed hay feverJournal of Allergy and Clinical Immunology, 1983
- Studies on allergoids from naturally occurring allergens IV. Efficacy and safety of long-term allergoid treatment of ragweed hay feverJournal of Allergy and Clinical Immunology, 1981
- Isolation of haptenic material from ragweed pollenImmunochemistry, 1969